Apparel and footwear brand, Allbirds, has designed what is dubbed “the world’s first zero-carbon shoe,” called M0.0nShot.
The shoe is made from carbon-negative materials such as merino wool, sugarcane-based foam, and bioplastic eyelets manufactured from a polymer formed from converted methane.
According to Allbirds, the M0.0nShot has a carbon footprint of 0.0 kilos CO2e, while the industry average is 14 kilograms CO2e.
The shoe will be unveiled in June during the Global Fashion Summit in Copenhagen.
Tim Brown, co-founder and co-CEO of Allbirds, says that creating a net zero carbon shoe that is commercially viable and scalable like the M0.0nShot is the culmination of their entire back catalog of work.
Brown added that while the M0.0nShot isn’t a silver bullet for the climate crisis, it’s a proof point that when people take sustainability seriously and are laser-focused on carbon reduction, incredible breakthroughs can happen.
Allbirds was the first fashion brand to label products with carbon footprints in 2020. A year later, the brand announced a collaboration with Adidas to create the world’s lowest-carbon shoe, the Adizero x Allbirds.


Japanese Yen Nears Seven-Month High as Oil Approaches $100
Columbia Student Mahmoud Khalil Fights Arrest as Deportation Case Moves to New Jersey
Google Revamps EU Search Results to Meet DMA Rules
Stuck in a creativity slump at work? Here are some surprising ways to get your spark back
German Inflation Accelerates to 2.9% in August
UK Food Inflation Forecast to Hit 6.4% by Mid-2027
China Buys 1 Million Tons of U.S. Soybeans Ahead of Xi Visit
Debate over H-1B visas shines spotlight on US tech worker shortages
The ghost of Robodebt – Federal Court rules billions of dollars in welfare debts must be recalculated
ECB Rate Hike in Focus as Oil Tops $100
Gold Prices Steady as Hot PPI Boosts Fed Rate Hike Bets
The American mass exodus to Canada amid Trump 2.0 has yet to materialize
Why have so few atrocities ever been recognised as genocide?
Anthropic Drops $6 Billion Decart AI Acquisition Talks
Novartis M&A Strategy Faces Investor Scrutiny After Drug Setbacks
The pandemic is still disrupting young people’s careers
OpenAI Weighs AI Development Slowdown Over Safety Risks 



